Global Drug-Eluting Stents Market Research Report 2021

Global Drug-Eluting Stents Market Research Report 2021

Table of Contents
1 Drug-Eluting Stents Market Overview
1.1 Product Overview and Scope of Drug-Eluting Stents
1.2 Drug-Eluting Stents Segment by Type
1.2.1 Global Drug-Eluting Stents Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Rapamycin
1.2.3 Paclitaxel
1.2.4 Everolimus
1.2.5 Others
1.3 Drug-Eluting Stents Segment by Application
1.3.1 Drug-Eluting Stents Sales Comparison by Application: (2021-2027)
1.3.2 Angina Pectoris
1.3.3 Myocardial Infarction
1.4 Global Drug-Eluting Stents Market Size Estimates and Forecasts
1.4.1 Global Drug-Eluting Stents Revenue 2016-2027
1.4.2 Global Drug-Eluting Stents Sales 2016-2027
1.4.3 Drug-Eluting Stents Market Size by Region: 2016 Versus 2021 Versus 2027
2 Drug-Eluting Stents Market Competition by Manufacturers
2.1 Global Drug-Eluting Stents Sales Market Share by Manufacturers (2016-2021)
2.2 Global Drug-Eluting Stents Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Drug-Eluting Stents Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Drug-Eluting Stents Manufacturing Sites, Area Served, Product Type
2.5 Drug-Eluting Stents Market Competitive Situation and Trends
2.5.1 Drug-Eluting Stents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug-Eluting Stents Players Market Share by Revenue
2.5.3 Global Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug-Eluting Stents Retrospective Market Scenario by Region
3.1 Global Drug-Eluting Stents Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Drug-Eluting Stents Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Drug-Eluting Stents Market Facts & Figures by Country
3.3.1 North America Drug-Eluting Stents Sales by Country
3.3.2 North America Drug-Eluting Stents Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug-Eluting Stents Market Facts & Figures by Country
3.4.1 Europe Drug-Eluting Stents Sales by Country
3.4.2 Europe Drug-Eluting Stents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug-Eluting Stents Market Facts & Figures by Region
3.5.1 Asia Pacific Drug-Eluting Stents Sales by Region
3.5.2 Asia Pacific Drug-Eluting Stents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drug-Eluting Stents Market Facts & Figures by Country
3.6.1 Latin America Drug-Eluting Stents Sales by Country
3.6.2 Latin America Drug-Eluting Stents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug-Eluting Stents Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug-Eluting Stents Sales by Country
3.7.2 Middle East and Africa Drug-Eluting Stents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Drug-Eluting Stents Historic Market Analysis by Type
4.1 Global Drug-Eluting Stents Sales Market Share by Type (2016-2021)
4.2 Global Drug-Eluting Stents Revenue Market Share by Type (2016-2021)
4.3 Global Drug-Eluting Stents Price by Type (2016-2021)
5 Global Drug-Eluting Stents Historic Market Analysis by Application
5.1 Global Drug-Eluting Stents Sales Market Share by Application (2016-2021)
5.2 Global Drug-Eluting Stents Revenue Market Share by Application (2016-2021)
5.3 Global Drug-Eluting Stents Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Boston Scientific Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic, Inc.
6.2.1 Medtronic, Inc. Corporation Information
6.2.2 Medtronic, Inc. Description and Business Overview
6.2.3 Medtronic, Inc. Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Medtronic, Inc. Product Portfolio
6.2.5 Medtronic, Inc. Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lepu Medical Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 MicroPort Scientific Corporation
6.5.1 MicroPort Scientific Corporation Corporation Information
6.5.2 MicroPort Scientific Corporation Description and Business Overview
6.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.5.4 MicroPort Scientific Corporation Product Portfolio
6.5.5 MicroPort Scientific Corporation Recent Developments/Updates
6.6 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Cook Medical Product Portfolio
6.6.5 Cook Medical Recent Developments/Updates
6.7 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Terumo Product Portfolio
6.7.5 Terumo Recent Developments/Updates
6.8 Biosensors International
6.8.1 Biosensors International Corporation Information
6.8.2 Biosensors International Description and Business Overview
6.8.3 Biosensors International Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biosensors International Product Portfolio
6.8.5 Biosensors International Recent Developments/Updates
6.9 Balton
6.9.1 Balton Corporation Information
6.9.2 Balton Description and Business Overview
6.9.3 Balton Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Balton Product Portfolio
6.9.5 Balton Recent Developments/Updates
6.10 AlviMedica Medical Technologies
6.10.1 AlviMedica Medical Technologies Corporation Information
6.10.2 AlviMedica Medical Technologies Description and Business Overview
6.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.10.4 AlviMedica Medical Technologies Product Portfolio
6.10.5 AlviMedica Medical Technologies Recent Developments/Updates
6.11 Biotronik
6.11.1 Biotronik Corporation Information
6.11.2 Biotronik Drug-Eluting Stents Description and Business Overview
6.11.3 Biotronik Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Biotronik Product Portfolio
6.11.5 Biotronik Recent Developments/Updates
6.12 Shandong JW Medical
6.12.1 Shandong JW Medical Corporation Information
6.12.2 Shandong JW Medical Drug-Eluting Stents Description and Business Overview
6.12.3 Shandong JW Medical Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Shandong JW Medical Product Portfolio
6.12.5 Shandong JW Medical Recent Developments/Updates
6.13 Sino Medical
6.13.1 Sino Medical Corporation Information
6.13.2 Sino Medical Drug-Eluting Stents Description and Business Overview
6.13.3 Sino Medical Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sino Medical Product Portfolio
6.13.5 Sino Medical Recent Developments/Updates
6.14 Beijing AMSINO
6.14.1 Beijing AMSINO Corporation Information
6.14.2 Beijing AMSINO Drug-Eluting Stents Description and Business Overview
6.14.3 Beijing AMSINO Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Beijing AMSINO Product Portfolio
6.14.5 Beijing AMSINO Recent Developments/Updates
6.15 Liaoning Biomedical Materials R&D Center Co.(LBC)
6.15.1 Liaoning Biomedical Materials R&D Center Co.(LBC) Corporation Information
6.15.2 Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Description and Business Overview
6.15.3 Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Liaoning Biomedical Materials R&D Center Co.(LBC) Product Portfolio
6.15.5 Liaoning Biomedical Materials R&D Center Co.(LBC) Recent Developments/Updates
7 Drug-Eluting Stents Manufacturing Cost Analysis
7.1 Drug-Eluting Stents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug-Eluting Stents
7.4 Drug-Eluting Stents Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug-Eluting Stents Distributors List
8.3 Drug-Eluting Stents Customers
9 Drug-Eluting Stents Market Dynamics
9.1 Drug-Eluting Stents Industry Trends
9.2 Drug-Eluting Stents Growth Drivers
9.3 Drug-Eluting Stents Market Challenges
9.4 Drug-Eluting Stents Market Restraints
10 Global Market Forecast
10.1 Drug-Eluting Stents Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug-Eluting Stents by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Drug-Eluting Stents by Type (2022-2027)
10.2 Drug-Eluting Stents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug-Eluting Stents by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Drug-Eluting Stents by Application (2022-2027)
10.3 Drug-Eluting Stents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug-Eluting Stents by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Drug-Eluting Stents by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Drug-Eluting Stents Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Drug-Eluting Stents Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Drug-Eluting Stents Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Drug-Eluting Stents Covered in This Study
Table 5. Global Drug-Eluting Stents Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Drug-Eluting Stents Sales Share by Manufacturers (2016-2021)
Table 7. Global Drug-Eluting Stents Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Drug-Eluting Stents Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Drug-Eluting Stents Manufacturing Sites and Area Served
Table 11. Manufacturers Drug-Eluting Stents Product Type
Table 12. Global Drug-Eluting Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug-Eluting Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Eluting Stents as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug-Eluting Stents Sales by Region (2016-2021) & (K Units)
Table 16. Global Drug-Eluting Stents Sales Market Share by Region (2016-2021)
Table 17. Global Drug-Eluting Stents Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Drug-Eluting Stents Sales by Country (2016-2021) & (K Units)
Table 19. North America Drug-Eluting Stents Sales Market Share by Country (2016-2021)
Table 20. North America Drug-Eluting Stents Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Drug-Eluting Stents Revenue Market Share by Country (2016-2021)
Table 22. Europe Drug-Eluting Stents Sales by Country (2016-2021) & (K Units)
Table 23. Europe Drug-Eluting Stents Sales Market Share by Country (2016-2021)
Table 24. Europe Drug-Eluting Stents Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Drug-Eluting Stents Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Drug-Eluting Stents Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Drug-Eluting Stents Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Drug-Eluting Stents Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Drug-Eluting Stents Revenue Market Share by Region (2016-2021)
Table 30. Latin America Drug-Eluting Stents Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Drug-Eluting Stents Sales Market Share by Country (2016-2021)
Table 32. Latin America Drug-Eluting Stents Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Drug-Eluting Stents Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Drug-Eluting Stents Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Drug-Eluting Stents Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Drug-Eluting Stents Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Drug-Eluting Stents Revenue Market Share by Country (2016-2021)
Table 38. Global Drug-Eluting Stents Sales (K Units) by Type (2016-2021)
Table 39. Global Drug-Eluting Stents Sales Market Share by Type (2016-2021)
Table 40. Global Drug-Eluting Stents Revenue (Million US$) by Type (2016-2021)
Table 41. Global Drug-Eluting Stents Revenue Share by Type (2016-2021)
Table 42. Global Drug-Eluting Stents Price (USD/Unit) by Type (2016-2021)
Table 43. Global Drug-Eluting Stents Sales (K Units) by Application (2016-2021)
Table 44. Global Drug-Eluting Stents Sales Market Share by Application (2016-2021)
Table 45. Global Drug-Eluting Stents Revenue (Million US$) by Application (2016-2021)
Table 46. Global Drug-Eluting Stents Revenue Share by Application (2016-2021)
Table 47. Global Drug-Eluting Stents Price (USD/Unit) by Application (2016-2021)
Table 48. Boston Scientific Corporation Information
Table 49. Boston Scientific Description and Business Overview
Table 50. Boston Scientific Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Boston Scientific Drug-Eluting Stents Product
Table 52. Boston Scientific Recent Developments/Updates
Table 53. Medtronic, Inc. Corporation Information
Table 54. Medtronic, Inc. Description and Business Overview
Table 55. Medtronic, Inc. Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Medtronic, Inc. Drug-Eluting Stents Product
Table 57. Medtronic, Inc. Recent Developments/Updates
Table 58. Abbott Corporation Information
Table 59. Abbott Description and Business Overview
Table 60. Abbott Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Abbott Drug-Eluting Stents Product
Table 62. Abbott Recent Developments/Updates
Table 63. Lepu Medical Corporation Information
Table 64. Lepu Medical Description and Business Overview
Table 65. Lepu Medical Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Lepu Medical Drug-Eluting Stents Product
Table 67. Lepu Medical Recent Developments/Updates
Table 68. MicroPort Scientific Corporation Corporation Information
Table 69. MicroPort Scientific Corporation Description and Business Overview
Table 70. MicroPort Scientific Corporation Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. MicroPort Scientific Corporation Drug-Eluting Stents Product
Table 72. MicroPort Scientific Corporation Recent Developments/Updates
Table 73. Cook Medical Corporation Information
Table 74. Cook Medical Description and Business Overview
Table 75. Cook Medical Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Cook Medical Drug-Eluting Stents Product
Table 77. Cook Medical Recent Developments/Updates
Table 78. Terumo Corporation Information
Table 79. Terumo Description and Business Overview
Table 80. Terumo Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Terumo Drug-Eluting Stents Product
Table 82. Terumo Recent Developments/Updates
Table 83. Biosensors International Corporation Information
Table 84. Biosensors International Description and Business Overview
Table 85. Biosensors International Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Biosensors International Drug-Eluting Stents Product
Table 87. Biosensors International Recent Developments/Updates
Table 88. Balton Corporation Information
Table 89. Balton Description and Business Overview
Table 90. Balton Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Balton Drug-Eluting Stents Product
Table 92. Balton Recent Developments/Updates
Table 93. AlviMedica Medical Technologies Corporation Information
Table 94. AlviMedica Medical Technologies Description and Business Overview
Table 95. AlviMedica Medical Technologies Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. AlviMedica Medical Technologies Drug-Eluting Stents Product
Table 97. AlviMedica Medical Technologies Recent Developments/Updates
Table 98. Biotronik Corporation Information
Table 99. Biotronik Description and Business Overview
Table 100. Biotronik Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Biotronik Drug-Eluting Stents Product
Table 102. Biotronik Recent Developments/Updates
Table 103. Shandong JW Medical Corporation Information
Table 104. Shandong JW Medical Description and Business Overview
Table 105. Shandong JW Medical Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Shandong JW Medical Drug-Eluting Stents Product
Table 107. Shandong JW Medical Recent Developments/Updates
Table 108. Sino Medical Corporation Information
Table 109. Sino Medical Description and Business Overview
Table 110. Sino Medical Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Sino Medical Drug-Eluting Stents Product
Table 112. Sino Medical Recent Developments/Updates
Table 113. Beijing AMSINO Corporation Information
Table 114. Beijing AMSINO Description and Business Overview
Table 115. Beijing AMSINO Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Beijing AMSINO Drug-Eluting Stents Product
Table 117. Beijing AMSINO Recent Developments/Updates
Table 118. Liaoning Biomedical Materials R&D Center Co.(LBC) Corporation Information
Table 119. Liaoning Biomedical Materials R&D Center Co.(LBC) Description and Business Overview
Table 120. Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Product
Table 122. Liaoning Biomedical Materials R&D Center Co.(LBC) Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Drug-Eluting Stents Distributors List
Table 126. Drug-Eluting Stents Customers List
Table 127. Drug-Eluting Stents Market Trends
Table 128. Drug-Eluting Stents Growth Drivers
Table 129. Drug-Eluting Stents Market Restraints
Table 130. Global Drug-Eluting Stents Sales Forecast by Type (2022-2027) & (K Units)
Table 131. Global Drug-Eluting Stents Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Drug-Eluting Stents Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Drug-Eluting Stents Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Drug-Eluting Stents Sales Forecast by Application (2022-2027) & (K Units)
Table 135. Global Drug-Eluting Stents Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Drug-Eluting Stents Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Drug-Eluting Stents Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Drug-Eluting Stents Sales Forecast by Region (2022-2027) & (K Units)
Table 139. Global Drug-Eluting Stents Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Drug-Eluting Stents Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Drug-Eluting Stents Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug-Eluting Stents
Figure 2. Global Drug-Eluting Stents Market Share by Type in 2020 & 2027
Figure 3. Rapamycin Product Picture
Figure 4. Paclitaxel Product Picture
Figure 5. Everolimus Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug-Eluting Stents Market Share by Application in 2020 & 2027
Figure 8. Angina Pectoris
Figure 9. Myocardial Infarction
Figure 10. Global Drug-Eluting Stents Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Drug-Eluting Stents Market Size 2016-2027 (US$ Million)
Figure 12. Global Drug-Eluting Stents Sales 2016-2027 (K Units)
Figure 13. Global Drug-Eluting Stents Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Drug-Eluting Stents Sales Share by Manufacturers in 2020
Figure 15. Global Drug-Eluting Stents Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Drug-Eluting Stents Players: Market Share by Revenue in 2020
Figure 17. Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Drug-Eluting Stents Sales Market Share by Region (2016-2021)
Figure 19. Global Drug-Eluting Stents Sales Market Share by Region in 2020
Figure 20. Global Drug-Eluting Stents Revenue Market Share by Region (2016-2021)
Figure 21. Global Drug-Eluting Stents Revenue Market Share by Region in 2020
Figure 22. U.S. Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Drug-Eluting Stents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Drug-Eluting Stents by Type (2016-2021)
Figure 47. Sales Market Share of Drug-Eluting Stents by Application (2016-2021)
Figure 48. Sales Market Share of Drug-Eluting Stents by Application in 2020
Figure 49. Revenue Share of Drug-Eluting Stents by Application (2016-2021)
Figure 50. Revenue Share of Drug-Eluting Stents by Application in 2020
Figure 51. Manufacturing Cost Structure of Drug-Eluting Stents
Figure 52. Manufacturing Process Analysis of Drug-Eluting Stents
Figure 53. Drug-Eluting Stents Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs